Pharma Reviews: HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trials

The Indian drug regulator has also granted permission for the restricted ... was a new technology and never used for vaccine manufacturing in India.
Read more: HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trials